Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
43.55
-0.13 (-0.30%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $2.25 billion as of August 21, 2026. Its market cap has increased by 454.33% in one year.
Market Cap
2.25B
Enterprise Value
2.30B
1-Year Change
454.33%
Ranking
Category
Stock Price
$43.55
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $2.25B, an increase of 310.17%. That is a compound annual growth rate of 28.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.25B | 103.32% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 2.13B |
| Stoke Therapeutics | 2.12B |
| Aurinia Pharmaceuticals | 2.10B |
| Biohaven | 2.10B |
| Kardigan | 2.09B |
| Sarepta Therapeutics | 2.07B |
| Taysha Gene Therapies | 2.07B |
| Septerna | 2.05B |